Terms: = Ovarian cancer AND KLF4, EZF, 9314, ENSG00000136826, GKLF, O43474 AND Treatment
16 results:
1. Anti-ovarian cancer actions and pharmacological targets of plumbagin.
Liang K; Pan X; Chen Y; Huang S
Naunyn Schmiedebergs Arch Pharmacol; 2023 Jun; 396(6):1205-1210. PubMed ID: 36692828
[TBL] [Abstract] [Full Text] [Related]
2. The deubiquitinase OTUD1 inhibits non-small cell lung cancer progression by deubiquitinating and stabilizing klf4.
Ma X; Wang L; Shi G; Sun S
Thorac Cancer; 2022 Mar; 13(5):761-770. PubMed ID: 35098684
[TBL] [Abstract] [Full Text] [Related]
3. Development and in vitro characterisation of an induced pluripotent stem cell model of ovarian cancer.
Bindhya S; Sidhanth C; Krishnapriya S; Garg M; Ganesan TS
Int J Biochem Cell Biol; 2021 Sep; 138():106051. PubMed ID: 34343671
[TBL] [Abstract] [Full Text] [Related]
4. EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/klf4 axis.
Wang K; Wang Y; Wang Y; Liu S; Wang C; Zhang S; Zhang T; Yang X
Stem Cell Res Ther; 2021 Mar; 12(1):186. PubMed ID: 33726845
[TBL] [Abstract] [Full Text] [Related]
5. iPSC-Derived Hereditary Breast cancer Model Reveals the
Portier L; Desterke C; Chaker D; Oudrhiri N; Asgarova A; Dkhissi F; Turhan AG; Bennaceur-Griscelli A; Griscelli F
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513753
[TBL] [Abstract] [Full Text] [Related]
6. Combined Poziotinib with Manidipine treatment Suppresses ovarian cancer Stem-Cell Proliferation and Stemness.
Lee H; Kim JW; Lee DS; Min SH
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036254
[TBL] [Abstract] [Full Text] [Related]
7. Cross‑validation of genes potentially associated with neoadjuvant chemotherapy and platinum‑based chemoresistance in epithelial ovarian carcinoma.
Zhang K; Wang W; Chen L; Liu Y; Hu J; Guo F; Tian W; Wang Y; Xue F
Oncol Rep; 2020 Sep; 44(3):909-926. PubMed ID: 32705213
[TBL] [Abstract] [Full Text] [Related]
8. The Effect of 3'-Hydroxy-3,4,5,4'-Tetramethoxy -stilbene, the Metabolite of the Resveratrol Analogue DMU-212, on the Motility and Proliferation of ovarian cancer Cells.
Nowicki A; Skupin-Mrugalska P; Jozkowiak M; Wierzchowski M; Rucinski M; Ramlau P; Krajka-Kuzniak V; Jodynis-Liebert J; Piotrowska-Kempisty H
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046103
[TBL] [Abstract] [Full Text] [Related]
9. Celastrol strongly inhibits proliferation, migration and cancer stem cell properties through suppression of Pin1 in ovarian cancer cells.
Li X; Wang H; Ding J; Nie S; Wang L; Zhang L; Ren S
Eur J Pharmacol; 2019 Jan; 842():146-156. PubMed ID: 30389635
[TBL] [Abstract] [Full Text] [Related]
10. DNA methylation and Transcriptome Changes Associated with Cisplatin Resistance in ovarian cancer.
Lund RJ; Huhtinen K; Salmi J; Rantala J; Nguyen EV; Moulder R; Goodlett DR; Lahesmaa R; Carpén O
Sci Rep; 2017 May; 7(1):1469. PubMed ID: 28473707
[TBL] [Abstract] [Full Text] [Related]
11. klf4 expression enhances the efficacy of chemotherapy drugs in ovarian cancer cells.
Wang B; Shen A; Ouyang X; Zhao G; Du Z; Huo W; Zhang T; Wang Y; Yang C; Dong P; Watari H; Pfeffer LM; Yue J
Biochem Biophys Res Commun; 2017 Mar; 484(3):486-492. PubMed ID: 28108288
[TBL] [Abstract] [Full Text] [Related]
12. Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells.
Kim DK; Seo EJ; Choi EJ; Lee SI; Kwon YW; Jang IH; Kim SC; Kim KH; Suh DS; Seong-Jang K; Lee SC; Kim JH
Exp Mol Med; 2016 Aug; 48(8):e255. PubMed ID: 27561949
[TBL] [Abstract] [Full Text] [Related]
13. KCNN4 and S100A14 act as predictors of recurrence in optimally debulked patients with serous ovarian cancer.
Zhao H; Guo E; Hu T; Sun Q; Wu J; Lin X; Luo D; Sun C; Wang C; Zhou B; Li N; Xia M; Lu H; Meng L; Xu X; Hu J; Ma D; Chen G; Zhu T
Oncotarget; 2016 Jul; 7(28):43924-43938. PubMed ID: 27270322
[TBL] [Abstract] [Full Text] [Related]
14. Trichostatin A-induced apoptosis is mediated by Kruppel-like factor 4 in ovarian and lung cancer.
Zohre S; Kazem NK; Abolfazl A; Mohammad RY; Aliakbar M; Effat A; Zahra D; Hassan D; Nosratollah Z
Asian Pac J Cancer Prev; 2014; 15(16):6581-6. PubMed ID: 25169491
[TBL] [Abstract] [Full Text] [Related]
15. Epimorphin-induced MET sensitizes ovarian cancer cells to platinum.
Yew KH; Crow J; Hirst J; Pessetto Z; Godwin AK
PLoS One; 2013; 8(9):e72637. PubMed ID: 24039787
[TBL] [Abstract] [Full Text] [Related]
16. Cost-minimization analysis of pegylated liposomal doxorubicin versus topotecan for the treatment of ovarian cancer in Italy.
Capri S; Cattaneo G
Clin Ther; 2003 Jun; 25(6):1826-45. PubMed ID: 12860501
[TBL] [Abstract] [Full Text] [Related]
